Results 41 to 50 of about 10,004,929 (375)

What’s New in Clinical Oncology? Highlights from the 2009 ASCO Annual Meeting

open access: yesCancer Biology & Medicine, 2009
This review summarizes the major advances in clinical oncology presented at the 2009 ASCO annual meeting, with emphasis on studies that are potentially practice-changing. Emerging new drugs are also discussed.
Xiaolong JIAO, YIlian YUAN
doaj   +1 more source

Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

open access: yesThe Journal of the National Comprehensive Cancer Network, 2021
Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis.
M. Tempero   +35 more
semanticscholar   +1 more source

The Investigation into the Board Examinations in Majors Related to Adult Cancer in Iran [PDF]

open access: yesمجله ایرانی آموزش در علوم پزشکی, 2020
Introduction: National Board exam is one of the important ways of assessment throughout a physician’s life span. This exam could be considered as the major director for acquiring knowledge during the residency educational program.
Masih Sabouri   +2 more
doaj  

RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens

open access: yesBiomedicines, 2020
RNA sequencing is considered the gold standard for high-throughput profiling of gene expression at the transcriptional level. Its increasing importance in cancer research and molecular diagnostics is reflected in the growing number of its mentions in ...
Maxim Sorokin   +10 more
doaj   +1 more source

Changes in Health State Utility Values in Japanese Patients with End-Stage Breast Cancer

open access: yesCurrent Oncology, 2021
We aimed to determine the dynamic trends in health state utility values (HSUVs) in patients with end-stage breast cancer. We selected 181 patients comprising 137 with primary breast cancer (PBC) and 44 with metastatic breast cancer (MBC) (28 survivors ...
Tsuguo Iwatani   +2 more
doaj   +1 more source

Clinical neuro-oncology for the neurologist [PDF]

open access: yesNeurology Clinical Practice, 2020
Neuro-oncologic patients are routinely encountered in clinical practice. Neuro-oncology is a rapidly evolving field, so understanding the most classic paradigms and contemporary advances will optimize patient care.We discuss the recent reclassification of tumors via molecular characteristics as it applies to direct clinical practice and review the ...
Rimas V. Lukas   +3 more
openaire   +5 more sources

Cytochrome P17 inhibition with ketoconazole as treatment for advanced granulosa cell ovarian tumor [PDF]

open access: yes, 2013
Originally published by the American Society of Clinical Oncology. García-Donas et al.: Journal of Clinical Oncology Vol.
Albareda, Judith   +8 more
core   +2 more sources

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.

open access: yesJournal of Clinical Oncology, 2020
PURPOSE To develop recommendations for management of patients with breast cancer (BC) with germline mutations in BC susceptibility genes. METHODS The American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of ...
N. Tung   +18 more
semanticscholar   +1 more source

Clinical trials in oncology [PDF]

open access: yes, 2018
Klinične raziskave ali klinična preskušanja so raziskave, ki vključujejo ljudi. Na njihovih izsledkih temelji vsakodnevna obravnava bolnikov, zdravljenje, ki temelji na dokazih. Klinična preskušanja razvrščamo v več faz.
Matos, Erika
core   +2 more sources

Liquid profiling for cancer patient stratification in precision medicine – current status and challenges for successful implementation in standard care

open access: yesJournal of Laboratory Medicine, 2022
Circulating tumor DNA (ctDNA), accurately described by the term liquid profiling (LP), enables real-time assessment of the tumor mutational profile as a minimally invasive test and has therefore rapidly gained traction, particular for the management of ...
Haselmann Verena   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy